GTHP - Guided Therapeutics, Inc.

OTC BB - OTC BB Delayed Price. Currency in USD

Guided Therapeutics, Inc.

5835 Peachtree Corners East
Suite D
Norcross, GA 30092
United States

IndustryMedical Appliances & Equipment
Full Time Employees10

Key Executives

NameTitlePayExercisedYear Born
Mr. Gene S. Cartwright Ph.D.Chief Exec. Officer, Pres, Acting Chief Financial Officer and Director254.99kN/A1954
Dr. Mark L. Faupel Ph.D.Chief Operating Officer and Director132.56kN/A1955
Mr. Richard L. FowlerSr. VP of Engineering and Sec.130kN/A1956
Mr. Charles RufaiControllerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. The company focuses on marketing LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. It is also developing a non-invasive esophageal cancer detection product using its biophotonic technology platform. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is based in Norcross, Georgia.

Corporate Governance

Guided Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.